Clinical Trials on B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma an in France
Total 187 results
-
Hospices Civils de LyonRecruitingPatients With Diffuse Large B-cell Lymphoma Treated With CART-cellsFrance
-
University Hospital, CaenCNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, FranceCompletedUntreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma PatientsFrance
-
WepromRecruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaFrance
-
Hospices Civils de LyonNot yet recruitingDiffuse Large B-cell Lymphoma (DLBCL) | CAR-T Cells TreatmentFrance
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa Associated Lymphoid TissueFrance
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma | Acute Lymphoblastic Leukemia (ALL)France
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States
-
Centre Henri BecquerelNot yet recruitingDiffuse Large B Cell LymphomaFrance
-
National Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Double-Expressor Lymphoma | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise... and other conditionsUnited States
-
Hospices Civils de LyonCompleted
-
Centre Antoine LacassagneRecruitingDiffuse Large B Cell LymphomaFrance
-
Institut Claudius RegaudAstraZenecaActive, not recruitingDiffuse Large B-cell LymphomaFrance
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
Centre Hospitalier Universitaire DijonNot yet recruitingFollicular Lymphoma | Diffuse Large Cell Diffuse LymphomaFrance
-
University Hospital, MontpellierRecruitingDiffuse Large B Cell LymphomaFrance
-
Centre Henri BecquerelNot yet recruitingDiffuse Large B Cell LymphomaFrance
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedChronic Lymphocytic Leukemia | Primary Central Nervous System Lymphoma | Diffuse Large B-cell Lymphoma | Indolent Non-hodgkin LymphomaFrance
-
Epizyme, Inc.CompletedB-cell Lymphomas (Phase 1) | Advanced Solid Tumors (Phase 1) | Diffuse Large B-cell Lymphoma (Phase 2) | Follicular Lymphoma (Phase 2) | Transformed Follicular Lymphoma | Primary Mediastinal Large B-Cell LymphomaAustralia, Canada, France, Germany, Italy, Poland, Taiwan, Ukraine, United Kingdom, United States
-
Molecular Templates, Inc.TerminatedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell Lymphoma | Non-hodgkin Lymphoma,B CellUnited States
-
WepromIncyte Corporation; Resilience CareNot yet recruitingDiffuse Large B Cell LymphomaFrance
-
Nantes University HospitalCompletedLymphoma, Large-Cell, DiffuseFrance
-
Hoffmann-La RocheRecruitingDiffuse Large B-Cell Lymphoma (DLBCL)United States
-
WepromRecruitingDiffuse Large B Cell LymphomaFrance
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
National Cancer Institute (NCI)CompletedDiffuse Large B Cell LymphomaFrance
-
French Innovative Leukemia OrganisationTerminated
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Merck Sharp & Dohme LLCRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaAustralia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
The Lymphoma Academic Research OrganisationCompletedDiffuse Large B Cell LymphomaFrance
-
Hospices Civils de LyonCompletedTo Characterize and Compare Clinical, Pathological and Molecular FeaturesFrance
-
ADC Therapeutics S.A.RecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaJapan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
Novartis PharmaceuticalsActive, not recruitingDiffuse Large B-cell LymphomaSpain, Germany, Canada, Italy, Hong Kong, China, Japan, France, United States, Singapore
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large-Cell LymphomaFrance, Belgium
-
Calithera Biosciences, IncTerminatedDiffuse Large B-cell LymphomaSpain, United States, Italy, Canada, France, United Kingdom
-
Lymphoma Study AssociationFondation ARCCompletedLymphoma, Large-Cell, DiffuseFrance, Belgium
-
Lymphoma Study AssociationCompletedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Centre Leon BerardNational Cancer Institute, FranceTerminatedDiffuse Large B Cell LymphomaFrance
-
Lymphoma Study AssociationTerminatedCD20-Positive Large B-Cell LymphomaFrance
-
Novartis PharmaceuticalsRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Large B-cell LymphomaJapan, Australia, Germany, Italy, Spain, France, Austria, United States
-
The Lymphoma Academic Research OrganisationLymphoma Study AssociationNot yet recruitingRefractory High Grade B-Cell Lymphoma | Diffuse Large B-cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaFrance
-
Hospices Civils de LyonActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaFrance
-
Lymphoma Study AssociationFondation ARCTerminatedLymphoma, Large-Cell, DiffuseFrance, Switzerland, Belgium
-
BayerCompletedDiffuse, Large B-Cell, LymphomaBelgium, France, Canada, Korea, Republic of, Australia, Germany, United Kingdom, Italy, Denmark, Singapore
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Follic Lymph to Diff Large B-Cell Lymphoma | Transformed Marg Zone Lymph to Diff...United States
-
Lymphoma Study AssociationEli Lilly and Company; Hoffmann-La Roche; Sanofi-SynthelaboCompletedDiffuse Large Cell LymphomaFrance
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell TypeUnited States, Saudi Arabia
-
Lymphoma Study AssociationBayerCompletedLymphoma, Large Cell, DiffuseFrance
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance